Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer

Chinese Journal of Cancer Research

Volumn 26, Issue 1, 2014, Pages 95-103

  Yin, Jie ^a   Bai, Zhigang ^a   Song, Jianning ^a   Yang, Yun ^a   Wang, Jin ^a   Han, Wei ^a   Zhang, Jun ^a   Meng, Hua ^a   Ma, Xuemei ^a   Yang, Yao ^a   Wang, Tingting ^a   Li, Weirong ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer (CRC); Diagnosis; Liver metastasis; MicroRNA (miRNAs)

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 141; MICRORNA 200B; MICRORNA 200C; MICRORNA 206; MICRORNA 21; MICRORNA 31; MICRORNA 335; MICRORNA LET7A; MICRORNA LET7B; MICRORNA LET7C; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UPREGULATION;

EID: 84901419130     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2014.02.07     Document Type: Article

References (31)

1. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244:254-9. (Pubitemid 44305540)
2. Aldrighetti L, Castoldi R, Di Palo S, et al. Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases. Chir Ital (In Italian) 2005;57:555-70.
3. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009;9:703-11.
4. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009;27:5848-56.
5. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J 2008;14:1-6.
6. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8. (Pubitemid 40839735)
7. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
8. Cheng H, Zhang L, Cogdell DE, et al. Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011;6:e17745.
9. Vickers MM, Bar J, Gorn-Hondermann I, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis 2012;29:123-32.
10. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-36. (Pubitemid 351185951)
11. Zhang W, Winder T, Ning Y, et al. A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol 2011;22:104-9.
12. King CE, Wang L, Winograd R, et al. LIN28B fosters colon cancer migration, invasion, and transformation through let-7 dependent and independent mechanisms. Oncogene 2011;30:4185-93.
13. Akao Y, Nakagawa Y. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6.
14. Han HB, Gu J, Zuo HJ, et al. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol 2012;226:544-55.
15. Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-52.
16. Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-tomesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013;62:1315-26.
17. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008;283:14910-4.
18. Gibbons DL, Lin W, Creighton CJ, et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009;23:2140-51.
19. Valastyan S, Reinhardt F, Benaich N, et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis. Cell 2009;137:1032-46.
20. Valastyan S, Benaich N, Chang A, et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev 2009;23:2592-7.
21. Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 2009;69:7495-8.
22. Ruzzo A, Graziano F, Vincenzi B, et al. High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease. Oncologist 2012;17:823-9.
23. Wang F, Zhang P, Ma Y, et al. NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett 2012;314:223-31.
24. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-36. (Pubitemid 351485639)
25. Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007;282:14328-36. (Pubitemid 47100416)
26. Toiyama Y, Takahashi M, Hur K, et al. Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer. J Natl Cancer Inst 2013;105:849-59.
27. Hansen TF, Andersen CL, Nielsen BS, et al. Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer. Oncol Lett 2011;2:1101-6.
28. Zhang Y, Yang P, Sun T, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 2013;15:284-94.
29. Png KJ, Halberg N, Yoshida M, et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2011;481:190-4.
30. Ren G, Kang Y. A one-two punch of miR-126/126* against metastasis. Nat Cell Biol 2013;15:231-3.
31. Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008;68:6416-24.